Market closedNon-fractional

Veru/VERU

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Veru

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

Ticker

VERU

Sector

Consumer Non-Cyclicals

Trading on

NASDAQ

Industry

Personal Care Products

Headquarters

Miami, United States

Employees

189

Veru Metrics

BasicAdvanced
$139M
Market cap
-
P/E ratio
-$0.37
EPS
-0.47
Beta
-
Dividend rate
$139M
-0.47
4.718
3.922
26.627
28.73
-16.92%
-40.76%
-125.82%
7.512
3.09
3.65
-2.539
-36.67%
-78.21%
-35.41%
279.25%

What the Analysts think about Veru

Analyst Ratings

Majority rating from 5 analysts.
Buy

Veru Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-243.90% profit margin
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$4.1M
95.24%
Net income
-$10M
21.95%
Profit margin
-243.90%
-37.54%

Veru Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 31.25%
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$0.07
-$0.12
-$0.08
-$0.07
-
Expected
-$0.21
-$0.24
-$0.10
-$0.05
-$0.06
Surprise
-134.15%
-48.94%
-22.58%
31.25%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Veru stock?

Veru (VERU) has a market cap of $139M as of July 06, 2024.

What is the P/E ratio for Veru stock?

The price to earnings (P/E) ratio for Veru (VERU) stock is 0 as of July 06, 2024.

Does Veru stock pay dividends?

No, Veru (VERU) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Veru dividend payment date?

Veru (VERU) stock does not pay dividends to its shareholders.

What is the beta indicator for Veru?

Veru (VERU) has a beta rating of -0.47. This means that it has an inverse relation to market volatility.

Buy or sell Veru stock

Buy or sell Veru stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing